- Call for Abstracts
- Sponsorship and Exhibition
Dr Johannes Czernin, MD
Professor of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, USA
Dr. Johannes Czernin
Johannes Czernin has 30 years of experience in nuclear medicine and molecular imaging. He is a Professor of Molecular and Medical Pharmacology in the David Geffen School of Medicine at UCLA and serves as the Chief of the Ahmanson Translational Imaging Division. His work focuses on improving the outcomes of cancer patients by developing novel diagnostic and therapeutic approaches. The major focus of his research team is the development of a translational theranostics program and the identification of effective combination between radioligand therapies and pharmacologic approaches. The current focus is prostate cancer to improve the results of radionuclide (radioligand) therapies that requires an understanding of resistance mechanisms that limit the effectiveness of theranostic approaches. He has published more than 250 manuscripts and currently serves as the Editor in Chief of the Journal of Nuclear.
Professor Vicky Goh
Head of Department, Cancer Imaging, School of Biomedical Engineering and Imaging Science, King’s College London, UK
Professor Vicky Goh
Professor Vicky Goh graduated from the University of Cambridge and completed her sub-speciality training in Clinical Radiology in London and Toronto, Canada. She is currently the Chair and Head of Department of Cancer Imaging at the School of Biomedical Engineering and Imaging Sciences, King’s College London and Honorary Consultant Radiologist at Guy’s and St Thomas’ Hospitals, London. Her research encompasses functional imaging in cancer (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography), tumour heterogeneity, radiomics and AI with a focus on gastrointestinal, genitourinary, lung and advanced cancers. She is the Chair of the Royal College of Radiologists Academic Committee, past president of the European Society of Oncologic Imaging, and European School of Radiology Steering Committee member and European Congress of Radiology Programme Planning Committee member. She sits on the Editorial Board of Radiology and European Radiology.
Associate Professor Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, FSNMMI
Associate Professor of Radiology, Associate Professor of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA
Dr. Hossein Jadvar
Dr. Hossein Jadvar is a tenured associate professor of radiology and biomedical engineering at the University of Southern California (USC) in Los Angeles, California. He received his BS in chemical engineering from Iowa State University in Ames, IA, in 1982, followed by a MS in biomedical engineering from the University of Wisconsin in Madison, WI, in 1984, and a MS in computer engineering, as well as a PhD in bioengineering, both from the University of Michigan in Ann Arbor, MI, in 1986 and 1988, respectively. He then attended the University of Chicago, Pritzker School of Medicine, in Chicago, IL, for his MD degree (1993). He received his master’s in public health (MPH) degree from Harvard University in Cambridge, MA, in 2005 and an Executive master’s in business administration (MBA) from USC in 2007. He was an intern in internal medicine at the University of California San Francisco, CA, during 1993-94, a diagnostic radiology and nuclear medicine resident at Stanford University, in Stanford, CA, during 1994-98, and a clinical fellow in positron emission tomography with the Harvard Medical School Joint Program in Nuclear Medicine, in Boston, MA, during 1998-99. He has also completed a number of executive educational certificate programs at Harvard Medical School in Boston, MA, the University of Cambridge in the UK, the University of Oxford in the UK, and the Wharton School of Business at the University of Pennsylvania in Philadelphia, PA. He has served as a visiting associate in bioengineering at the California Institute of Technology (Caltech) in Pasadena, CA. Dr. Jadvar is on the leadership editorial boards of the Journal of Nuclear Medicine, the European Journal of Nuclear Medicine and Molecular Imaging, Molecular Imaging and Biology, Radiology (Consultant to the Editor), American Journal of Roentgenology (Assistant Editor), and Clinical Nuclear Medicine (Deputy Editor), and is on the editorial board of many other journals. He is a fellow and past president of the American College of Nuclear Medicine (ACNM) as well as past president and fellow of the Society of Nuclear Medicine and molecular imaging (SNMMI). He is the past recipient of the SNMMI Mark Tetalman Young Investigator Award, the Western Regional SNMMI Distinguished Scientist Award, the Academy of Radiology Research Distinguished Investigator Award, the inaugural fellowship in the USC Center for Excellence in Research, the inaugural Prof. Ajit Padhy Oration Award from the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), and the Best Clinical Mentor Award from USC and the ACNM. He is a National Institutes of Health (NIH) funded investigator and serves on multiple NIH review panels (with one term as a chartered member on the medical imaging, MEDI, panel), the Department of Defense, and the Imaging Technology and Informatics Peer Review Panel of the Cancer Prevention and Research Institute of Texas (CPRIT). He is an International Atomic Energy Agency (IAEA) expert on the nuclear medicine panel. He has written more than 130 journal articles, has published 3 books, 30 book chapters, 9 patents, numerous conference abstracts and full articles, and has given more than 250 invited speaker presentations at national and international venues. His research interests include applications of PET in clinical outcome research and in translational molecular imaging research with particular current interest in prostate cancer and theranostics. (http://www-hsc.usc.edu/~jadvar)
Dale Bailey PhD FIPEM FACPSEM ARCP (Lond.) CSci (UK)
Principal Physicist in the Department of Nuclear Medicine at Royal North Shore Hospital, Professor of Medical Radiation Sciences at the University of Sydney.
Dale Bailey is Principal Physicist in the Department of Nuclear Medicine at Royal North Shore Hospital and Professor of Medical Radiation Sciences at the University of Sydney. He has published over 150 peer-reviewed scientific articles and edited four textbooks. He is the project leader for the Translational Theranostics programme of Sydney Vital – the Northern Translational Cancer Research Centre, Sydney. His main area of interest has been in the development of quantitative techniques for imaging of in vivo radionuclide tracers in both SPECT and PET and, more recently, internal radionuclide dosimetry. The Royal North Shore group have made a number of contributions in dosimetry including SIR-Spheres therapy and biodistribution of theranostic agents such as 64/67Cu and 177Lu. Dale is the immediate President of the Australian and New Zealand Society of Nuclear Medicine.
Professor Eva Bezak, PhD, FACPSEM
Professor in Medical Radiation, Medical Radiation I School of Health Sciences, University of South Australia, Australia
Professor Eva Bezak
Eva Bezak is a Professor in Medical Radiations at the University of South Australia. Previously she was a Chief Physicist at Department of Medical Physics, Royal Adelaide Hospital, providing services to radiation oncology in South Australia (SA). She has authored and co-authored over 110 publications, 200 conference presentations and co-authored books on radiotherapy physics, radiation biology and novel therapies. She is actively involved in a number of development projects and organising committees, related to radiotherapy infrastructure, establishment of new radiotherapy centres, staff education and training, scientific meetings, policy development. She has been involved in development of national and state cancer plans for radiation oncology. She is currently appointed a member on the South Australian Radiation Protection Committee. She is an active member of medical physics professional community in Australia. In 2010-2011, Prof Bezak was elected the President of the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM), also serving as an Australian representative on the Asia-Pacific Federation of Medical Physics Committee. Recently, she was a member of the expert working group under the Australian Academy of Sciences to prepare a report on future accelerators in Australia. Currently, she is the chair of the Women in Medical Physics and Biomedical Engineering task group. In her spare time she likes to organize conferences.
Ms Kate Lamb
Lecturer in Medical Sonography, School of Health Sciences, University of South Australia, Australia
Ms Kate Lamb
Dr David Pattison, Acting-Deputy Director of the Department of Nuclear Medicine & PET Services
Royal Brisbane & Women’s Hospital
Dr David Pattison
Dr David Pattison graduated from University of Melbourne in 2003 and subsequently completed dual specialty training in both endocrinology and nuclear medicine at the Royal Melbourne Hospital, Austin Hospital and Peter MacCallum Cancer Centre in Melbourne. In 2016 moved from the Peter MacCallum Cancer Centre to his current role as Acting-Deputy Director of the Department of Nuclear Medicine & PET Services at the Royal Brisbane & Women’s Hospital. He has a keen clinical and research interest in molecular imaging and radionuclide therapy of endocrine malignancies (including neuroendocrine tumours and thyroid cancer) and prostate cancer. He is the lead nuclear medicine physician for radionuclide therapy at RBWH and has introduced a clinical I-124 PET service for management of advanced thyroid cancer.
Associate Professor Michael Penniment MBBS, FRANZCR, MBA,
Director of Radiation Oncology, Royal Adelaide Hospital
Visiting Radiation Oncologist, Alan Walker Cancer Care Centre Darwin, Northern Territory
Associate Professor Michael Penniment
A/Prof Michael Penniment is a Senior Radiation Oncologist with interests in the application of new technologies in radiotherapy and the provision of services to rural and remote areas. He was a foundation consultant at the North Queensland Oncology service and then planned and established the Alan Walker Cancer Care Centre (AWCCC) in Darwin.
The AWCCC has just completed a successful review of 7 years of operation and, under A/Prof Penniment’s lead, is a good example of Federal capital infrastructure funding excellence in cancer treatment. His unit at the new RAH was the first service to open at RAH, one month ahead of schedule.
He was involved in Australia’s first National Proton Advisory Committee and has since lead the SA Government team looking to establish a centre in the new Adelaide health precinct. He completed his MBA studies, during a period where his team were involved in evaluating new efficient synchrotron proton therapy solutions.
He has held key positions in the College (RANZCR) such as Government and Regulatory Affairs Committee (2003-2010), Faculty Board member (2006-2011), Education Board (1997-2006, 2011-2013), Economics and Workforce Committee (RANZCR 2011-2013),and is currently a lead in the Particle therapy group within the faculty.
A/Prof Penniment has been invited to join the founding board of the Asian Particle Therapy Society linking Australia with the teams in Japan, Korea, China and Taiwan.
He is involved in a number of national and international research projects, in particular in the areas of business planning for new radiation facilities, improving indigenous cancer care, and quality of life in cancer treatment. In 2017 he was engaged to review the radiation oncology operations of a number of public centres in Victoria, looking specifically at the sustainability of their business model and to revise their leadership structure and service delivery.
A/Prof Penniment was awarded the TROG excellence in trial research for his palliative oesophageal trial following on from selection for Best of ASTRO in the USA in 2014, and ASCO GIT 2015.
Associate Professor Geoff Currie,
Associate Professor in Nuclear Medicine, Charles Sturt University
A/Prof Geoff Currie
A/Prof Geoff Currie was appointed in Medical Radiation Science at Charles Sturt University in 2002. Geoff has a Bachelors Degree in Pharmacy, Masters Degree in Medical Radiation Science (nuclear medicine), a Masters Degree in Applied Management (health), a Masters Degree in Business Administration (MBA) and a Doctor of Philosophy (PhD). Geoff has broad research and teaching interests across the medical radiation sciences and, indeed, health generally with more than 125 peer reviewed journal papers, editor of 5 books, 120+ conference presentations and a reviewer for 25 international journals.
Geoff trained at St Vincent's Hospital in Sydney before relocating to Royal Prince Alfred Hospital (RPAH) for a senior appointment. After undertaking positron emission tomography (PET) training at the University of California, Los Angeles (UCLA), he returned to RPAH to a senior role in Australia's first PET department. After this, Geoff entered the private arena where he established departments in Sydney and the Gold Coast before relocating to an established private company on the Central Coast of NSW. With several decades of clinical, management and research experience, a career in academia seemed logical and Geoff commenced his career at CSU in 2002. Geoff has Adjunct / Conjoint appointments at several other universities in Australia and the USA. Geoff is International Consulting Editor of the Journal of Nuclear Medicine Technology.
Dr Berry Allen
Nuclear Medicine Scientist, Department Head of Nuclear Medicine, Waikato Hospital, Hamilton, New Zealand
Berry Allen is head of the Nuclear Medicine department, Waikato Hospital, DHB (District Health Board), Hamilton, New Zealand. Berry initially trained and qualified as a Medical Radiation Therapist at Waikato Hospital, obtaining the Diploma of Radiation Therapy (UK), and elected to subsequently pursue a career in Nuclear Medicine, obtaining his Nuclear Medicine qualification undertaking training at the London Hospital, and Royal Marsden Hospital, UK, later undertaking computer science qualifications at Waikato university, and Master of Nuclear Medicine Science degree, and a Doctor of Philosophy (PhD), Newcastle university, Australia 2006.
Berry was a member of the New Zealand Nuclear Medicine Training Board, and national examiner, and has authored and coauthored 25+ articles, and given presentations at 60 meetings and conferences. Berry is actively involved in student and Registrar training, and clinical trials, is an Auckland University Health Faculty, Medical Imaging advisor and Board member, an IANZ assessor, and a New Zealand Ministry of Health, Health Practitioners Disciplinary Tribunal member.
Waikato Hospital Nuclear Medicine department provides a regional service to the Waikato, and central north island, and as such undertakes a wide range of molecular imaging and in-vitro services. Berry has a particular interest in Cardiac, Neuroendocrine, and tumour imaging.
Professor Ian Olver, AM
Director, University of South Australia Cancer Research Insititute
Professor of Translational Cancer Research
Professor Ian Olver, AM
Professor Ian Olver, AM is Director, University of South Australia Cancer Research Insititute and Professor of Translational Cancer Research. A renowned oncologist, cancer researcher and bioethicist his research interests are in anticancer drug studies, symptom control, bio-ethics and psycho-oncology, Ian is author of over 290 journal articles and is a regular commentator on cancer issues in Australia and internationally.
Ian was appointed a Member of the Order of Australia (AM) for service to medical oncology as a clinician, researcher, administrator and mentor, and to the community through leadership roles with cancer control organisations.
Ian Olver graduated MB, BS from the University of Melbourne in 1976, was awarded an MD in 1991 and completed a PhD from Monash University in bioethics in 1997. He also holds a Certificate of Ministry (Lay Preaching) from the Adelaide College of Divinity. He is a Fellow of the Royal Australasian College of Physicians (FRACP), its Chapter of Palliative Medicine (FAChPM) an Associate Fellow of the Royal Australian College of Medical Administrators (ARACMA) and a Fellow of the Australian Academy of Health and Medical Science.
He trained as a medical oncologist at Peter MacCallum Cancer Institute, the Alfred Hospital, Melbourne and the University of Maryland Cancer Centre in Baltimore. He practised at Peter MaCallum and then at The Royal Adelaide Hospital where he became Clinical Director of the RAH Cancer Centre, set up tele-oncology links with Darwin, established an oncology clinic in Alice Springs and trained the first medical oncologist for the CMC Hospital in Vellore India. From May 2006 to December 2014 he was appointed CEO, Cancer Council Australia in Sydney and received their Gold Medal in 2104
He is a past chair of the Medical Oncology Group of Australia and received their Cancer Achievement award in 2008. He currently chairs the Australian Health Ethics Committee of NHMRC and sits on NHMRC Council. He is President of the Multinational Association of Supportive Care in Cancer.
Professor Christopher Rowe MD FRACP
Director Australian Dementia Network, Director Molecular Imaging Research, Austin Health, University of Melbourne
Professor Christopher Rowe MD FRACP
Professor Christopher Rowe FRACP MD is Director of Molecular Imaging Research and a consultant neurologist to the Memory Disorders Clinic at the Austin Hospital, Melbourne. He introduced amyloid PET imaging into Australia in 2004 and has been imaging leader for AIBL since its inception in 2006. Professor Rowe and his team apply state-of-the-art neuroimaging technology to develop new diagnostic tests and biomarkers and support early intervention clinical trials in Alzheimer’s disease. Professor Rowe is a leader in the field of imaging AD and is in the “Highly Cited” list of the top1% of scientists by citations world-wide.
Associate Professor Nathan Better
Associate Professor Nathan Better
He trained in internal medicine and cardiology at the Austin Hospital in Melbourne and then completed nuclear medicine training at the Repatriation Hospital and Alfred Hospital. Following this, he undertook a Fellowship program at Harvard Medical School based at the Brigham and Women’s Hospital in Boston, U.S.A. This was in the Joint Program in Nuclear Medicine, with a special interest in nuclear cardiology. He subsequently completed a Cardiology Fellowship at the West Roxbury VA Hospital in Boston before returning to Melbourne.
Since returning in 1994, A/Prof Better has based his clinical private cardiology practice at Cabrini Hospital in Melbourne. He is available for GP and specialist referrals and practises in a full range of cardiology services, including coronary disease, heart failure, cardiac rhythm disturbance, hypertension, lipid management and preventative cardiology. In 1996, he set up the Nuclear Cardiology service at Cabrini and continues to work there as a nuclear medicine physician in Nuclear Cardiology and General Nuclear Medicine.
A/Prof Better also works at the Royal Melbourne Hospital as a clinical cardiologist and is the Deputy Director of Nuclear Medicine. He is involved in the full range of nuclear medicine procedures. He has completed training in cardiac CT and in 2007 helped set up that facility at Royal Melbourne, where he remains actively involved in the service. In 2015, he also completed training in PET and will be involved at both Royal Melbourne and Cabrini Health in their new PET facilities.
He has a special interest in post-graduate teaching and is heavily involved with the education of cardiology and nuclear medicine registrars. He also plays a central role in the training and preparation of internal medicine basic trainees for the FRACP Part 1 Internal Medicine examinations.
A/Prof Better’s research interests include the role of cardiac imaging in diagnosis and prognosis and radiation safety. He is involved with the International Atomic Energy Agency (IAEA) in Vienna, Austria as an expert lecturer and researcher and in setting up practice guidelines. He has also undertaken teaching appointments in Vienna and throughout Asia.
A/Prof Better’s personal interests include travel and soccer. He is married and has 4 children. He is committed to patient care, both inpatient and outpatient, and to medical education and maintains a strong interest in clinical research.
Associate Professor Roslyn Francis
Head of Department, Sir Charles Gairdner Hospital Nuclear Medicine/WA PET Service
A/Prof Roslyn Francis
Ros Francis is Head of Department at Sir Charles Gairdner Hospital Nuclear Medicine/WA PET Service and is Associate Professor of Molecular Imaging with University of Western Australia. Her research interests in Oncology include semi-quantitative volumetric response evaluation to therapy with FDG PET and the evaluation of novel PET tracers in a number of tumour types including mesothelioma, glioma, hepatocellular carcinoma, pancreatic cancer and prostate cancer. More recently she has also collaborated on projects in Neurology, Cardiology, infection imaging and in health economics. She has an interest in personalised medicine and currently supervises three PhD students. In 2014 A/Prof Francis was appointed the inaugural scientific chair of Australasian Radiopharmaceutical Trials Network (ARTnet), which was established to facilitate collaborative multicentre clinical trials with radiopharmaceuticals in Australasia. A/Prof Francis is the Vice President of ANZSNM.